Core Viewpoint - The global wearable wristband device market is experiencing steady growth, with shipments reaching 193 million units in 2024, a 4% year-on-year increase, driven primarily by strong demand in China and emerging markets, compensating for declines in mature markets like the US and India [1][2]. Group 1: Market Performance - In 2024, China remains the largest market for wearable wristband devices, accounting for 30% of global shipments with a 20% year-on-year growth, significantly boosted by government subsidies and product upgrades [1][2]. - The Indian market, as the second-largest, faces challenges with a 22% decline in shipments due to local manufacturers struggling with upgrades in basic watch functionalities [1][2]. Group 2: Emerging Markets - Emerging markets play a crucial role in global growth, with the Middle East leading at a 55% increase, followed by Southeast Asia (45%), Latin America (21%), and Eastern Europe (20%) [2]. - Brands like Xiaomi and Huawei are enhancing brand recognition to drive growth in these regions, focusing on affordable basic devices to attract first-time buyers [2]. Group 3: Product Segmentation - Basic watches continue to be the main growth driver, with an 8% increase in 2024 following a 25% rise in 2023, while basic wristbands are seeing a revival with a 7% growth in Q3 and a significant 49% increase in Q4 [3]. - The demand for simple, lightweight, non-intrusive wearable devices is evident, particularly in health and fitness tracking, alongside a growing trend for smart rings [3]. Group 4: Competitive Landscape - Samsung re-entered the basic fitness wristband market with the Galaxy Fit 3, intensifying competition and prompting Xiaomi to adjust pricing and distribution strategies in various markets [4]. - Samsung's strategy aims to attract new users to its health ecosystem through entry-level devices, eventually guiding them towards smartwatches [4]. Group 5: Future Outlook - The ongoing expansion of the wearable wristband device market in 2024 highlights the increasing demand for affordable devices in emerging markets, while mature markets face challenges due to longer upgrade cycles and stagnation in innovation [5]. - Future growth will depend on balancing innovation with affordability, expanding global market share, and leveraging emerging trends like smart rings and advanced health tracking [5].

2025年2月11日，美国 数字健康公司 Epicore Biosystems 宣布完成 2600万美元（约1.9亿人民币） 的 B轮融资 ，以支持其生物可穿戴技术的发展。 此次 B轮融资 由 斯蒂尔希望基金会（Steele Foundation for Hope） 领投。 公司希望通过这笔资金，扩大其云分析平台的应用，并扩展到新的生物标志物 目标，包括肾脏健康、女性健康、营养不良和环境毒素暴露。 Epicore 的技术旨在通过非侵入性的汗液分析，提供关于个人的水分、压力水平、营养和整体健康的实时洞察，并可通过传感器提醒佩戴者热损伤、脱水或营 养不良的风险。 # 研发背景 随着人们对健康重视程度的不断提高，以及对慢性疾病管理需求的增加，健康监测设备的需求也在迅速增长。传统的健康监测方法（如血液检测）虽然准确，但属 于有创操作，难以实现连续监测。 而汗液监测作为一种非侵入式监测手段，能够提供实时、连续的健康数据，满足人们对日常健康监测的需求。 汗液中含有多种生物标志物（如电解质、乳酸盐、皮质醇等） ，这些成分的变化可以反映身体的多种生理状态，包括水分流失、电解质平衡、肌肉疲劳和压力水平 等。例如，囊性纤维化患者 ...